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Abstract 
 Migraine is a common neurovascular disorder characterized by chronic episodic attacks of 
moderate to severe primary headache involving activation of trigeminal neurons. Despite its prevalence, 
the pathogenesis of migraine is not clearly understood. The pulsating nature of the headache suggests 
the involvement of the cranial vasculature in headache pathogenesis. However, current hypotheses 
emphasize the role of the trigeminal nociceptive system in the development of migraine, and other forms 
of primary headache. In these hypotheses, migraine pain is driven by the activation and sensitization of 
central trigeminal neurons driving the activation and sensitization of peripheral trigeminal neurons that 
innervate the meninges forming the trigeminocervical complex, which includes the caudal extension of 
trigeminal nucleus in the upper spinal cord. A better understanding of headache pathogenesis will pave 
the way for the development of more effective treatments.
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 Introduction
 Migraine is a highly prevalent and complex 
disorder. Migraine has an annual worldwide prevalence 
of about 6% in men and 16% in women that varies 
slightly across populations and cultures1. A survey of a 
community in Bangkok, Thailand found slightly higher 
one-year prevalence2. Although migraine does not 
cause permanent neurological damage, its symptoms 
are troublesome and can cause high burden in terms 
of socioeconomic cost. In 2005 it was estimated that 
the economic lost in European countries is about 27 
billion Euro per annum for 41 million patients. Migraine 
is ranked as the seventh highest cause of disability3, 4. In 
China, where costs are perhaps more aligned with those 
in Thailand, the total estimated annual cost in 2011 
of primary headache disorders, including migraine, 
tension-type headache, and chronic daily headache 
is Yuan 672.7 billion, accounting for 2.24% of gross 
domestic product (GDP) (direct cost: Yuan 108.8 billion, 
0.36% of GDP; indirect cost: Yuan 563.9 billion, 1.88% 
of GDP)5. With a 2011 GDP of THB 10.54 trillion (Office of 
the National Economic and Social Development Board, 
17 July 2012), by analogy with China, this puts the total 
monetary cost of headache in Thailand at around THB 
236 billion. This is without mentioning the unaccountable 
social costs of the pain and suffering of headache 
sufferers and their families. A better understanding of 
migraine is certainly warranted. 
 Migraine is characterized by the episodic 
recurrence of the associated headache. The duration of 
the headache ranges from 4 to 72 hours. Headache can 
be unilateral, as consistent with ancient observations 
by Galen of Pergamon used the term hemicrania (half-
head) for migraine, and may spread to another side. 
In some patients, headache is preceded by transient 
neurological deficits including visual alterations, altered 
somatic sensations, and dysphasia. This phase is 
called ‘aura’. Based on the presence or absence of 
aura, migraine can be classified as migraine with aura 
(MA) or migraine without aura (MO)6. Recent evidence 
suggests that migraine is the result of a complex 
interaction between environmental and genetic factors. 
The brains of migraineurs, or migraine sufferers, have 
shown abnormality in structure and function, which 
may lead to abnormality in sensory processing7, 8. 
Several mechanisms such as neurogenic inflammation, 
sensitization of the trigeminal nociceptive system, and 
dysfunction of the endogenous pain control system may 
be involved in the pathogenesis of migraine. 
 Pathogenesis of migraine
 In the 17th century, an early hypothesis for 
migraine was proposed by Thomas Willis with a vascular 
theory that “megrim” was the result of dilatation of blood 
vessels within the head. This hypothesis was supported 
in part by the observation that migraine intensity could 
sometimes be reduced by superficial temporal artery 
compression9. Towards the end of the 19th century, 
ergot, a potent vasoconstrictor agent, was introduced 
by W.H. Thomson as an effective remedy for migraine10.
 Harold G. Wolff was attributed with being 
the first to place migraine on a scientific basis in the 
early 20th century. He found that during migraine 
attacks, the temporal branches of the external carotid 
artery could be demonstrated by their pulsations. 
The vascular pulsation and headache was reduced 
either by superficial temporal artery compression or by 
injection of ergotamine (the first pure ergot alkaloid11). 
This finding further supported the role of cranial vessels 
in migraine pathogenesis. The so-called “vascular 
theory” proposed that migraine attack is characterized 
by initial constriction of intracranial vessels resulting 
in transient neurological deficits. Then, the process is 
followed by the vasodilation, which causes headache. 
However, some clinical features of migraine cannot 
be explained by the vascular theory. For example, the 
slowly progressive character of migraine aura does 
not comply with ischaemic process, and the spatial 
pattern of the neurological deficit cannot be explained 
by neurovascular distribution.
 Modern experiments have suggested the 
role of nervous system as primary process in migraine 
generation. For instance, cerebral blood flow changes 
can be induced by brainstem electrical stimulation12. This 
finding supported a “neurogenic theory” and stimulated 
researchers to investigate the relationship between the 
trigeminal nerve and the intracranial vasculature. The 
trigeminal nerve has strong anatomical relationship 
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with the cranial vessels13. Moskowitz and colleagues 
described that activation of trigeminovascular axons 
causes a release of vasoactive peptides from their 
terminals. An inflammatory reaction and activation of 
trigeminal nociceptive terminals surrounding the cranial 
vessels was observed in their animal subjects14. This 
response is called “trigeminal vascular reflex” and 
was believed to play an important role in migraine 
pathogenesis.
	 Neurogenic	inflammation
 Neurogenic inflammation was described 
in 1910 by Bruce, who showed that application of 
mustard oil into the conjunctiva sac in animal models 
induced inflammation that could be inhibited by sensory 
nerve ablation15. This observation was consistent with 
the antidromic sensory vasodilatation observed by 
others. Neurogenic inflammation was recognized as 
a physiological process of inflammation produced 
by the nervous system. In the context of migraine, 
vasoactive neuropeptides, such as calcitonin gene 
related peptide (CGRP), substance P (SP), and 
neurokinin A (NKA), were released from trigeminal 
and parasympathetic perivascular fibers, and evoked 
vasodilatation, plasma protein extravasation, and the 
release of other proinflammatory mediators. Neurogenic 
inflammation consists of two distinct and independent 
physiological components, namely neurogenic plasma 
protein extravasation and neurogenic vasodilatation16. 
Plasma protein extravasation is a phenomenon that 
allows macromolecules, including albumin, to pass 
through the endothelial gaps in postcapillary venules 
into the interstitial space and produces an inflammatory 
edema17. The leakage occurs following stimulation 
of peripheral sensory nerves. Direct stimulation of 
sensory nerves in rodents elicits the peripheral release 
of vasoactive neuropeptides18. The effects of SP and 
NKA are mediated by G-protein-coupled receptor, 
NK1 receptor, expressed on the endothelial cells of 
postcapillary venules and collecting vessels. NK1 
receptor is associated with Gq/11 proteins and its 
stimulation results in the mobilization of Ca2+ ions into 
the cytosol, where it activates intracellular contractile 
elements. Within seconds of NK1 receptor activation, 
endothelial gaps form because of the contraction of 
the endothelial cells. This allows plasma proteins to 
leak out of the blood vessels. The gaps are located at 
the intracellular junctions of endothelial cells and are 
reversible19.
 Although experiments in rodent models of 
migraine suggest that plasma protein extravasation 
(PPE) in the meninges could by an important mechanism 
in migraine pathogenesis, various antagonists with a 
good pharmacodynamics and pharmacokinetic profile 
were not effective in clinical trials20,21. The embarrassing 
lack of clinical effectiveness of these antagonists 
demonstrated that even if SP and NKA were released 
from human sensory neurons, they did not produce 
the PPE commonly observed in rodents, and thus 
PPE probably does not play any role in migraine. On 
the other hand, the role of the other components of 
neurogenic inflammation, the neurogenic vasodilatation, 
in mediating migraine pain has received much more 
attention in the recent years22. This process is mediated 
via the activation of CGRP receptors expressed on 
vascular smooth muscle cells.
	 Trigeminovascular	sensitization:	 the	
role of cortical spreading depression
 Pain receptors, or nociceptors, in facial and 
intracranial structures receive input from trigeminal 
innervation and send nociceptive signals to higher 
brain centres. Although activation of the trigeminal 
nociceptive system and release of CGRP and SP from 
trigeminal nociceptor are known to be essential steps 
in development of migraine pain, little is known about 
the way these processes are activated. Because 
headache is preceded by an aura in some patients, 
the mechanism underlying aura may have roles in 
trigeminal activation. It is generally accepted that 
transient neurological symptoms occurring during aura 
phase are likely to be explained by an experimentally 
observed electrophysiological phenomenon called 
cortical spreading depression that may be a homologue 
of aura in experimental animals.
 Cortical spreading depression (CSD) is a surge 
of electrophysiological cortical activity and followed by 
its inhibition. This wave-like surge usually starts in the 
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occipital cortex and gradually propagates forward over 
the cortex at about 3-5 mm per minute and disappears 
at the central sulcus. Based on the propagation of this 
phenomenon, CSD is consistent with the development 
of aura in migraine patients. CSD is caused by a 
transient disturbance of mechanisms maintaining ionic 
homoeostasis. These perturbations in ionic homoeostasis 
are characterized by extracellular negative direct 
current potential, indicating a cell depolarization. CSD 
can be induced in animals with non-noxious stimuli, 
and is frequently referred to in the literature as the 
“spreading depression of Leão”23. Although CSD was 
first demonstrated in lissencephalic brains of rodents, it 
can also occur in gyrencephalic brains. Using in vitro 
studies, CSD has been observed in human cortical brain 
tissue24, and in human hippocampus and striatum in 
vivo25.
 Accumulating evidence suggests that CSD 
can account for the pathogenesis of the migraine aura. 
However, the initiation of the migraine attack phase and 
CSD is not clearly understood. Previous experiments show 
that during CSD, several physiological measurements, 
including cortical blood flow, neurotransmitter levels, 
and extracellular ionic concentration can change. For 
instance, blood flow is increased in various brain areas 
such as cerebral cortex, hippocampus, and brainstem. 
The level of neurotransmitters such as glutamate, 
glycine, and nitric oxide (NO) have been shown to be 
increased in cerebral cortical tissue26,27. These chemical 
messengers may induce perivascular inflammation and 
activate or sensitize perivascular nociceptors during 
CSD. On the other hand, these chemical messengers 
may direct activate nociceptors and produce headache. 
This hypothesis is supported by work published in 
2004 by Maneesri and coworkers, who found that CSD 
can induce c-fos expression in the trigeminal nucleus 
caudalis (TNC) without perivascular inflammation28. 
 Dysfunction of the endogenous pain 
control system
 It is known that the excitability of TNC neurons 
is strongly influenced by supraspinal controls. Positron 
emission tomography (PET), and other brain imaging 
studies have demonstrated activation of the dorsal 
midbrain including the periaqueductal gray (PAG) and 
the locus coeruleus, thalamus, rostroventral medulla 
(RVM), and raphe nuclei, in migraine patients29,30,31,32. 
These brain areas exert their nociceptive modulation 
effect via downward projection to the trigeminocervical 
complex33. A derangement of this system at any level 
or a complex mechanism may decrease the sensitivity 
of pain perception and may increase the chance of 
generating a migraine headache. Experiments in animals 
showed that the development of long-term potentials 
in the dorsal horn synapse, a condition comparable to 
central sensitization, is facilitated when this endogenous 
antinociceptive system is impaired34. The clinical 
evidence indicates possible relationship between PAG 
dysfunction and headache pathogenesis. The PAG is a 
brain area with a descending antinociceptive function 
that has a strong influence on the trigeminocervical 
complex. Migraine-like headache sometimes occurs in 
the patients with electrodes implanted into the PAG for 
pain relief35.
 Serotonin (5-HT) plays an important role in 
the endogenous pain modulating system. It is known 
that migraine pathogenesis is associated with 5-HT 
depletion. A decrease of 5-HT concentration in platelets 
and an increase in plasma 5-HT correlated with migraine 
attacks in patients. However, the mechanism by which 
5-HT depletion predisposes the brain to migraine attack 
is not well understood. Experimental evidence from 
animal models of migraine shows that 5-HT depletion 
increases the frequency of CSD and that CSD induced 
c-fos expression in the second order neurons in the 
trigeminocervical complex36. Pretreatment with NO 
blockers can modulate cortical hyperexcitability and 
trigeminal nociception37. Other studies show that 
5-HT depletion can increase NR1 phosphorylation of 
the NMDA receptor and c-Fos expression in the TNC 
induced by dural inflammation38. Dysfunction of this 
neurotransmitter system may induce changes including 
an increase in cortical excitability, disinhibition of the 
descending pain control system, and activate the 
trigeminal nociceptive system in second order neurons 
in trigeminocervical complex.
30 Journal of Medicine and Health Sciences(Vol.21 No.2 August 2014)
 Conclusions
 This review describes some of the current 
knowledge regarding role of trigeminal system in 
migraine pathogenesis. The data from clinical and 
preclinical research indicates trigeminovascular 
sensitization and the derangement of endogenous pain 
control system as being important in the pathogenesis 
of migraine. The current concept regards migraine 
as a genetic predisposing condition. Various genetic 
abnormalities have been reported to contribute to 
migraine development especially in the forms with strong 
genetic predisposition such as familial hemiplegic 
migraine. The genes include CACNA1A (for P/Q calcium 
channel) SCN1 (for voltage controlled sodium channel) 
and ATP/A2 (for ion pump). Since most of these genes 
control the expression of protein involved in the control 
of membrane potential, their alterations may change the 
cellular excitability and increase the susceptibility of 
having CSD. CSD then activates the trigeminal system 
resulting in headache.
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